Matthieu Durand
Papers
1
Total Citations
2
H-Index
1
About
Matthieu Durand is a leading urological surgeon and researcher whose work centers on optimizing surgical outcomes in robotic-assisted partial nephrectomy (RAPN). His primary research areas include minimally invasive kidney cancer surgery, postoperative complication management, and the shift toward outpatient care models. Durand’s major contribution lies in identifying which patient populations can safely undergo early discharge after RAPN. His landmark study, "SAFE: Multi-institutional study of time to complications after robot-assisted partial nephrectomy" (UroCCR 90), analyzed the timing of postoperative complications to define eligibility for outpatient management. This work challenges the traditional 3-day hospital stay by demonstrating that a carefully selected cohort can be managed safely as outpatients, potentially reducing healthcare costs and improving patient recovery. With 2 citations, this 2024 study is already influencing clinical protocols. Durand’s research bridges the gap between surgical innovation and practical patient care, offering evidence-based guidelines that empower surgeons to shorten hospital stays without compromising safety. His findings are particularly valuable for trainees and clinicians seeking to implement enhanced recovery pathways in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1